Rx Bandz, LLC — Department of Defense SBIR Phase II: AF211-DCSO1
Rx Bandz, LLC — SBIR Phase II award from Department of Defense.
- Amount
- $749,947
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase II
- Topic
- AF211-DCSO1
- Solicitation
- X21.1
- NAICS
- —
- Place of performance
- TX
- Period
- 2021-08-06 → 2022-11-09
Description
Rx Bandz’ innovative MiniJect™ auto-injector can be adapted to deliver the analgesic hydromorphone to severely injured Airmen giving them and their units a better chance of remaining mobile and less exposed in theater and under fire.